Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Teligene logo — company profile

Teligene

Founded 2011 Series C Total: $600.00M Biotechnology, Health Care +1

General Information

Company Name Teligene
Founded Year 2011
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Teligene. To contact Teligene, visit teligene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Teligene compare?

A PDF of Teligene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Teligene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Teligene

Teligene is a high-tech pharmaceutical research and development company established in 2011. Specializing in the creation and industrialization of small molecule innovative drugs, the company's expertise lies in the development of international small molecule targeted anti-tumor drugs. With a seasoned senior technical management team, Teligene is well-versed in the latest drug development technologies and trends both domestically and internationally. In February 2021, the company secured a CNY600.00M Series C investment from ShenZhen GTJA Investment Group. Teligene's primary focus is on designing, screening, optimizing, and developing original small molecule targeted anti-tumor drugs with independent intellectual property rights. The company operates in the Biotechnology, Health Care, and Pharmaceutical industries, with a dedication to innovation and substantial growth potential.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY600.00M 1
ShenZhen GTJA Investment Group
24 Feb 2021
Series B Undisclosed 5
IDG Capital Shenzhen Capital Group Loyal Valley Capital
IDG Capital, Shenzhen Capital Group +3
17 Aug 2018

Teligene Alternatives & Competitors

View All Alternatives
Teligene vs
Advenchen Laboratories, LLC
Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...

Venture round
6 employees
Biotechnology, Health Care
Teligene vs
Forward Pharma
Forward Pharma

Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceutical...

Series B
Health Care, Pharmaceutical
Teligene vs
Panacos Pharmaceuticals
Panacos Pharmaceuticals

Innovative solutions in the fight against HIV and other viral diseases using advanced small-molecule...

Post-IPO Debt
Biotechnology, Health Care
View all alternatives

FAQ About Teligene

Established in 2011, Teligene is a high-tech pharmaceutical research and development company that focuses on the creation and industrialization of small molecule innovative drugs. The company's senior technical management team is highly experienced and well-versed in the latest drug development tech...
Teligene was founded in 2011.
Teligene operates in Biotechnology, Health Care and Pharmaceutical.
Teligene has completed 2 funding rounds, raising a total of $600.00M. The latest funding stage is Series C.
Top alternatives and competitors to Teligene include Advenchen Laboratories, LLC, Forward Pharma, Panacos Pharmaceuticals, Tarveda Therapeutics, Generian. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Teligene and Advenchen Laboratories, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Teligene, https://bouncewatch.com/company/teligene, updated 1 August 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes